Single-Lead ECG Monitor Market

Single-Lead ECG Monitor Market Outlook (2024 to 2034)

Revenue from the global single-lead ECG monitor market is evaluated to increase from US$ 669 million in 2024 to US$ 1.71 billion by the end of 2034. The market has been analyzed to increase at 9.8% CAGR from 2024 to 2034. Increasing prevalence of heart-related disorders is giving rise to the high demand for single-lead ECG monitors across the world.

An electrocardiogram (ECG) is a test to record the electrical signal in the heart. Sticky patches called electrodes are placed on the chest and sometimes on the arms and legs. These monitors make it quite easy for doctors to understand the heart condition and carry out the correct operation. In recent years, due to lifestyle changes and culinary changes, more people are complaining of heart problems, leading to a significant rise in sales of single-lead ECG monitors.

ECG monitors are non-invasive and painless and take only a few minutes to perform. Elderly people comparatively face more heart conditions and are unable to endure pain, and therefore, these ECG monitors are effective in helping them understand their heart condition. Increasing prevalence of heart diseases, particularly among the elderly, is projected to contribute to the expansion of the single-lead ECG monitor market size during the forecast period.

Key Market Growth Drivers

• In comparison to photoplethysmography, electrocardiography is widely utilized for heart rate recording due to its precision, providing accurate results. This precise analysis serves as a cornerstone for performing heart surgeries.
• Government investments in the healthcare sector to offer top-notch facilities to citizens act as a catalyst for the increased sales of technologically advanced single-lead ECG monitors.
• Modern ECG machines feature automated medical algorithms that interpret the heart's activity, enabling doctors to allocate their focus to other critical aspects of heart conditions. This streamlines processes, saving time for both medical professionals and patients.
• ECG monitors are applicable across all age groups and genders without adverse effects on the body, establishing them as pivotal tools in operating rooms for comprehending patients' heart conditions.
• Portable ECG devices have democratized heart rate monitoring, allowing individuals to conveniently measure their heart rate at home. Their portability enables heart patients to access necessary assistance anywhere, anytime.
• While traditional ECGs relied on wires, the introduction of wireless ECGs in recent years has revolutionized monitoring systems. These wireless setups find applications in diverse fields such as telemonitoring and sports applications.
• Manufacturers are channeling investments into research to develop low-cost, dependable, and portable ECG solutions to broaden their customer base. Advancements in healthcare technologies are driving worldwide single-lead ECG monitor market growth.

Report Attribute	Detail
Single-Lead ECG Monitor Market Size (2024E)	US$ 669 Million
Forecasted Market Value (2034F)	US$ 1.71 Billion
Global Market Growth Rate (2024 to 2034)	9.8% CAGR
Canada Market Growth Rate (2024 to 2034)	9.9% CAGR
Brazil Market Value (2034F)	US$ 44.1 Million
North America Market Share (2024E)	41.5%
Latin America Market Share (2034F)	5.7%
Key Companies Profiled	Dimetek Digital Medical Technologies Ltd.; AliveCor Inc.; Tianjin Chase Sun; Pharmaceutical Group; Ambisea Technology Corp.; Zenicor Medical Systems; OMRON Corporation; Perlong Medical Equipment Co.

Why are Single-Lead ECG Monitors Important in Assessing Heart Health?

“Rising Cases of Heart Disorders Necessitating Early Disease Detection”

Lifestyle disorders such as heart disease, atherosclerosis, stroke, obesity, type 2 diabetes, and other diseases linked to excessive alcohol use, smoking, and drug use are becoming more common. Heart disease and stroke are the most common illnesses globally, primarily due to poor lifestyle choices, unhealthy diets, increased tobacco use, and lack of physical activity.

Elevated glucose levels, high blood pressure, overweight, high blood lipids, and obesity are key indicators of heart disease that can be identified in primary care and hospitals. This has led to a rise in the use of single-lead ECG monitors among users worldwide.

“Increased R&D Efforts and Rising Adoption of Home Cardiac Care”

Growing use of single-lead electrocardiogram devices in sports activities for monitoring heart rate during exercise for cardiac assessment during self-triaging before using complex systems and the increasing importance of home care are driving the growth of this market. In addition, increased R&D efforts by various manufacturers are projected to attract many lucrative opportunities.

As a result of ongoing research and development, portable single-lead ECG devices have been developed that can diagnose arrhythmias, and syncope, and identify risks that may lead to cardiovascular issues.

• For instance, individuals with diabetes, hypertension, hypercholesterolemia, and obesity can use Omron Corporation's HeartScan ECG Monitor to assess their risk of cardiovascular disease. All these factors contribute to the market's growth.

Why are Some Doctors Hesitant to Use Single-Lead ECG Devices?

“Risk of Undetected Irregularities Leading to Patient Safety Concerns”

Though the market is projected to generate lucrative opportunities during the forecast period, several factors are hindering opportunities for manufacturers. One primary obstacle is that single-lead ECG devices only provide a snapshot of the heart’s activity at the time of the test. This limitation means that irregularities occurring between tests may go undetected, potentially leading to significant discrepancies in test results, causing harm to the heart and, in some cases, loss of life. Consequently, doctors are reluctant to rely solely on ECGs, significantly impacting sales. Suppliers in the market are focused on addressing this issue, aiming to regain their customer base and establish market dominance globally.

Country-wise Insights

Sales of single-lead ECG monitors are increasing at a significant pace worldwide, specifically in the United States, Canada, Mexico, Chile, and Brazil. The market in Canada is projected to advance at a CAGR of 9.9% from 2024 to 2034. The country is poised to occupy a single-lead ECG monitor market share of 13.5% in North America by the end of 2034.

Which Factor is Benefitting ECG Monitor Suppliers in the United States?

“Shift to Telemedicine Solutions and Real-Time Remote Monitoring”

Attribute	United States
Market Value (2024E)	US$ 223.9 Million
Growth Rate (2024 to 2034)	10% CAGR
Projected Value (2034F)	US$ 579.4 Million

Integration of digital technology into healthcare, particularly in the aftermath of the COVID-19 pandemic, has transformed the electrocardiogram patch and Holter monitoring business. One noteworthy single-lead ECG monitor market trend in the United States is the rapid shift to telemedicine solutions and real-time monitoring, ensuring immediate medical intervention. Suppliers are adapting to this change, looking for the right time to establish their business in the country and achieve significant profits.

Why are Suppliers of Single-Lead ECG Monitors Focusing on Brazil?

“Growing Medical Tourism Due to Affordable Treatment Options”

Attribute	Brazil
Market Value (2024E)	US$ 16.4 Million
Growth Rate (2024 to 2034)	10.4% CAGR
Projected Value (2034F)	US$ 44.1 Million

Increasing prevalence of cardiovascular diseases in Brazil, growing aging population, and ongoing healthcare infrastructure improvements present significant opportunities for providers of cardiac diagnostics. Additionally, more people in the country are becoming aware of the need for preventive care and early detection of cardiovascular disease.

Brazil has become a popular medical tourism destination due to its affordable treatment costs, attracting more individuals seeking advanced diagnosis and treatment. Government initiatives to improve healthcare accessibility, along with cooperation between manufacturers, hospitals, and cardiac centers, are projected to drive demand for advanced diagnostic ECG equipment during the forecast period.

Category-wise Analysis

According to Fact.MR, a research-based company, the market is divided into product type, application, and end user. Based on application, use of single-lead ECG monitors for diagnosing conduction disorders is analyzed to rise at a CAGR of 9.7%. This segment is set to occupy a single-lead ECG monitor market share of 32.5% in 2024.

Which ECG Product Type is Extensively Preferred by Doctors?

“Widespread Preference for Recording-Based Single-Lead ECG Monitors”

Attribute	Recording-Based Single-Lead ECG
Segment Value (2024E)	US$ 529.1 Million
Growth Rate (2024 to 2034)	9.9% CAGR
Projected Value (2034F)	US$ 1.36 Billion

Recording-based single-lead ECGs are getting used more prominently as they help record heart rates for future reference. In traditional ECG, there is no option to save the calculated data, making it hard for doctors to look for previous test data.

Which End User Accounts for High Sales of Single-Lead ECG Monitors?

“Availability of Large Number of Skilled Surgeons in Hospitals”

Attribute	Hospital Facilities
Segment Value (2024E)	US$ 347.6 Million
Growth Rate (2024 to 2034)	9.9% CAGR
Projected Value (2034F)	US$ 886.7 Million

Hospitals maintain large teams of doctors for surgeries and other cardiac procedures, necessitating a continuous need for ECG monitors to assess patients' heart rates before proceeding with operations. ECG monitors play an important role in heart surgeries by helping surgeons monitor patients, given the criticality of these surgeries.

Market Competition

To gain momentum in the industry, key players in the single-lead ECG monitor market are offering new and innovative goods. Furthermore, leading competitors are pursuing market expansion strategies such as mergers & acquisitions, partnerships, and collaborations, and making sure to adapt themselves to the evolving market trends such as ECG cables and lead wires and ECG telemetry devices.

• In September 2023, iRhythm Technologies, Inc. introduced its next-generation Zio® monitor and updated Zio® long-term continuous monitoring (LTCM) service in the United States. The Zio monitor is iRhythm's smallest, lightest, and thinnest cardiac monitor, with several service features that enhance the cardiac monitoring experience for both patients and healthcare providers.

Fact.MR provides detailed information about the price points of key single-lead ECG monitor manufacturers positioned across the world, sales growth, production capacity, and speculative technological expansion in this new market report.

Key Segments of Single-Lead ECG Monitor Market Research

• By Product Type :

  • Recording Based Single-Lead ECG Monitors
  • Real-time Single-lead ECG Monitors

• By Application :

  • Atrial Fibrillation
  • Bradycardia
  • Conduction Disorders
  • Tachycardia

• By End User :

  • Hospital Facilities
  • Home Care Settings
  • Other End Users

• By Region :

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa